documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
16 rows where docket_id = "FDA-2009-Q-0301" and posted_year = 2011 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, withdrawn, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-Q-0301-0032 | FDA | None FDA-2009-Q-0301 | FDA/CFSAN Office of Nutrition, Labeling, and Dietary Supplements to the Division of Dockets Management, June 27, 2011 - Letter | Other | Letter(s) | 2011-08-17T04:00:00Z | 2011 | 8 | 2011-08-17T04:00:00Z | 2011-08-17T17:39:26Z | 0 | 0 | 0900006480eb5f41 | ||
| FDA-2009-Q-0301-0027 | FDA | None FDA-2009-Q-0301 | FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation, April 11, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material | Supporting & Related Material | BKG-Background Material | 2011-06-09T04:00:00Z | 2011 | 6 | 2011-06-09T22:46:51Z | 0 | 0 | 0900006480e33fe2 | |||
| FDA-2009-Q-0301-0024 | FDA | None FDA-2009-Q-0301 | Consultation Between CDER DPARP and CFSAN on "Most Common Disease....", March 15, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2011-06-09T04:00:00Z | 2011 | 6 | 2011-06-09T22:46:44Z | 0 | 0 | 0900006480e33f1e | |||
| FDA-2009-Q-0301-0023 | FDA | None FDA-2009-Q-0301 | FDA/CDER Division of Dermatology and Dental Drug Products (DDDP), Medical Officer, Dermatology, Memorandum, April 21, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2011-06-09T04:00:00Z | 2011 | 6 | 2011-06-09T22:46:42Z | 0 | 0 | 0900006480e33f1c | |||
| FDA-2009-Q-0301-0022 | FDA | None FDA-2009-Q-0301 | FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation Final, April 5, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2011-06-09T04:00:00Z | 2011 | 6 | 2011-06-09T22:46:40Z | 0 | 0 | 0900006480e33f1a | |||
| FDA-2009-Q-0301-0025 | FDA | None FDA-2009-Q-0301 | FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation, March 14, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2011-06-09T04:00:00Z | 2011 | 6 | 2011-06-09T22:46:46Z | 0 | 0 | 0900006480e33fde | |||
| FDA-2009-Q-0301-0028 | FDA | None FDA-2009-Q-0301 | FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter | Other | LET-Letter | 2011-06-09T04:00:00Z | 2011 | 6 | 2011-06-09T04:00:00Z | 2013-07-27T23:55:27Z | 0 | 0 | 0900006480e439dd | ||
| FDA-2009-Q-0301-0029 | FDA | None FDA-2009-Q-0301 | Enclosure 1 - "Abbott Laboratories Comment to FDA/CFSAN/ONLDS" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028 | Supporting & Related Material | LET-Letter (Supporting and Related Material) | 2011-06-09T04:00:00Z | 2011 | 6 | 2011-06-09T23:14:57Z | 0 | 0 | 0900006480e373e2 | |||
| FDA-2009-Q-0301-0026 | FDA | None FDA-2009-Q-0301 | Comment on Typographical Emphasis on an Infant Formula QHC, April 12, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material | Supporting & Related Material | BKG-Background Material | 2011-06-09T04:00:00Z | 2011 | 6 | 2011-06-09T22:46:49Z | 0 | 0 | 0900006480e33fe0 | |||
| FDA-2009-Q-0301-0031 | FDA | None FDA-2009-Q-0301 | Enclosure 3 - "Toit, et al., Can Food Allergy be Prevented? The Current Evidence" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028 | Supporting & Related Material | 2011-06-09T00:00:00Z | 2011 | 6 | 2011-06-09T23:17:27Z | 0 | 1 | 0900006480e373e4 | ||||
| FDA-2009-Q-0301-0030 | FDA | None FDA-2009-Q-0301 | Enclosure 2 - "ASCIA Annual Scienific Meeting 2008 Abstracts" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028 | Supporting & Related Material | 2011-06-09T00:00:00Z | 2011 | 6 | 2011-06-09T23:17:53Z | 0 | 1 | 0900006480e373e3 | ||||
| FDA-2009-Q-0301-0019 | FDA | None FDA-2009-Q-0301 | FDA/CFSAN to Regulatory Discretion, Inc - Letter | Supporting & Related Material | LET-Letter (Supporting and Related Material) | 2011-06-02T04:00:00Z | 2011 | 6 | 2016-10-31T15:03:11Z | 0 | 0 | 0900006480e39a5c | |||
| FDA-2009-Q-0301-0020 | FDA | None FDA-2009-Q-0301 | FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 25, 2011 - Letter | Other | LET-Letter | 2011-06-02T04:00:00Z | 2011 | 6 | 2011-06-02T04:00:00Z | 2013-08-11T04:46:04Z | 0 | 0 | 0900006480e34a14 | ||
| FDA-2009-Q-0301-0018 | FDA | None FDA-2009-Q-0301 | Nestle Infant Nutrition to FDA/CFSAN, April 7, 2011 - Letter | Other | LET-Letter | 2011-05-18T04:00:00Z | 2011 | 5 | 2011-05-18T04:00:00Z | 2011-06-02T22:04:01Z | 0 | 0 | 0900006480d1e55c | ||
| FDA-2009-Q-0301-0015 | FDA | None FDA-2009-Q-0301 | FDA/CFSAN Memorandum to the Division of Dockets Management, February 23, 2011 - Memorandum | Other | M-Memorandum | 2011-03-04T05:00:00Z | 2011 | 3 | 2011-03-04T05:00:00Z | 2013-08-11T03:13:23Z | 0 | 0 | 0900006480bfb3b3 | ||
| FDA-2009-Q-0301-0017 | FDA | None FDA-2009-Q-0301 | Enclosure 1 - "...100% Whey-Protein Partially Hydrolyzed Infant Formula and Reduced Rist of Atopc Dermatitis" - [Nestle Infant Nutrition to FDA/CFSAN, November 8, 2010 - Letter] re FDA-2009-Q-0301-0016 | Supporting & Related Material | LET-Letter (Supporting and Related Material) | 2011-03-04T05:00:00Z | 2011 | 3 | 2011-03-05T00:13:07Z | 0 | 0 | 0900006480bfb3b5 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;